EDITORIAL
Published on 11 Jul 2019
Editorial: Peptidyl-Prolyl Isomerases in Human Pathologies
doi 10.3389/fphar.2019.00794
- 2,433 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Peptidyl-prolyl Isomerases in Human Pathologies
Peptidyl-prolyl Isomerases in Human Pathologies
15k
Total Downloads
80k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 05 Apr 2019
Pleiotropic Clostridioides difficile Cyclophilin PpiB Controls Cysteine-Tolerance, Toxin Production, the Central Metabolism and Multiple Stress Responses
doi 10.3389/fphar.2019.00340
- 3,150 views
- 7 citations
REVIEW
Published on 25 Feb 2019
Oncogenic Hijacking of the PIN1 Signaling Network
doi 10.3389/fonc.2019.00094
- 4,730 views
- 27 citations
MINI REVIEW
Published on 22 Jan 2019
A Guide to PIN1 Function and Mutations Across Cancers
doi 10.3389/fphar.2018.01477
- 6,876 views
- 18 citations
REVIEW
Published on 05 Dec 2018
FKBP Ligands—Where We Are and Where to Go?
doi 10.3389/fphar.2018.01425
- 46,407 views
- 117 citations
REVIEW
Published on 26 Nov 2018
PIN1 in Cell Cycle Control and Cancer
doi 10.3389/fphar.2018.01367
- 7,631 views
- 46 citations
ORIGINAL RESEARCH
Published on 23 Nov 2018
Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains
doi 10.3389/fphar.2018.01351
- 1,965 views
- 3 citations
ORIGINAL RESEARCH
Published on 13 Nov 2018
Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From Clostridium botulinum C2 Toxin
doi 10.3389/fphar.2018.01287
- 2,205 views
- 9 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Cancer Molecular Targets and TherapeuticsOffline
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 80kTopic views
- 64kArticle views
- 15kArticle downloads